Latest News about CELG
Recent news which mentions CELG
Market Crash 2.0: 3 Stocks to Save Your Portfolio
October 03, 2020
From Motley Fool
2 No-Brainer Stocks to Buy in Biotech
September 14, 2020
From Motley Fool
Amgen Blows Past EPS Estimates for the Second Quarter
July 29, 2020
From Motley Fool
From Motley Fool
How These 15 Stock Suggestions Fared Against the Market
April 28, 2020
From Motley Fool
Better Buy: bluebird bio vs. Gilead Sciences
February 12, 2020
From Motley Fool
Merck's Keytruda Could Face Direct Competition from New Chinese Drug
January 21, 2020
From Motley Fool
Here's Why Bristol-Myers Squibb Jumped 12.7% in December
January 05, 2020
From Motley Fool
Bristol-Myers Placed A Big Bet On Celgene’s Pipeline. Will It Pay Off For Investors?
December 16, 2019
From Motley Fool
Drugmakers have spent a record $342 billion on M&A in 2019
December 09, 2019
From MarketWatch
From Motley Fool
Here's Why Editas Medicine Jumped 45.3% in November
December 04, 2019
From Motley Fool
The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Arrowhead Earnings And More
November 24, 2019
From Benzinga
AstraZeneca CEO: Closing In On A Cancer Cure
November 22, 2019
From Benzinga
The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon
November 21, 2019
From Benzinga
From Motley Fool
What Happened in the Stock Market Today
November 18, 2019
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing
November 14, 2019
From Benzinga
Editas Expands Its Celgene Partnership After Another Strong Quarter
November 13, 2019
From Motley Fool
The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
November 13, 2019
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
November 12, 2019
From Benzinga
Why Celgene's Latest FDA Approval Makes Bristol-Myers Squibb's Dividend Look Even Better
November 12, 2019
From Motley Fool
Why Bristol-Myers Squibb Stock Gained 13% in October
November 11, 2019
From Motley Fool
Better Buy: Biogen vs. Celgene
November 10, 2019
From Motley Fool
Stocks That Hit 52-Week Highs On Friday
November 08, 2019
From Benzinga
Acceleron's Q3 Results Focus Squarely on Its Celgene Collaboration
November 06, 2019
From Motley Fool
AstraZeneca Named The Most Innovative Global Pharma Company
November 06, 2019
From Benzinga
Buy These 2 Stocks to Access China's Huge Healthcare Market
November 06, 2019
From Motley Fool
Here's Why Beigene Stock Is Soaring Today
November 01, 2019
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.